Skip to content

All recalls FDA

FDADrugsRecalled Status: Completed

Baxter Healthcare Corporation recalls Ondansetron Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed pH Specifications
Products
  • Ondansetron Injection
Where it was sold

Nationwide in the USA

Nationwide

Units affected
6,022,675 vials
About this recall
Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25